Trial intelligence / Profile preview

Deoxyepinephrine infusion dose in obese vs non-obese pregnant women undergoing cesarean section spinal anesthesia

ChiCTR2200058519Phase 4Not yet recruiting

Sponsor
Linping District Women and Children Care Hospital
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of deoxyepinephrine in intraoperative hypotension (IOH) (2 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Continuous infusion dose of deoxyepinephrine. Planned start Mar 2022; status: not yet recruiting.

02

Drugs

deoxyepinephrine
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on ChiCTR2200058519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200058519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call